Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
46.62
+0.59 (1.28%)
At close: Mar 26, 2026, 4:00 PM EDT
47.56
+0.94 (2.02%)
Pre-market: Mar 27, 2026, 5:26 AM EDT
Sanofi Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Sanofi stock has a target of 58, which predicts a 24.41% increase from the current stock price of 46.62.
Price Target: $58 (+24.41%)
Analyst Consensus: Buy
* Price targets were last updated on Sep 8, 2025.
Analyst Ratings
The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 3 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 16, 2026 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 9, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $56 → $58 | Hold → Buy | Upgrades | $56 → $58 | +24.41% | Sep 8, 2025 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 2, 2025 |
Financial Forecast
Revenue This Year
48.12B
from 46.72B
Increased by 3.01%
Revenue Next Year
50.92B
from 48.12B
Increased by 5.80%
EPS This Year
8.48
from 6.37
Increased by 32.99%
EPS Next Year
8.94
from 8.48
Increased by 5.50%
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 54.5B | 56.7B | |||
| Avg | 48.1B | 50.9B | |||
| Low | 44.9B | 47.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.8% | 17.9% | |||
| Avg | 3.0% | 5.8% | |||
| Low | -3.9% | -2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.40 | 10.40 | |||
| Avg | 8.48 | 8.94 | |||
| Low | 5.88 | 6.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 63.1% | 22.6% | |||
| Avg | 33.0% | 5.5% | |||
| Low | -7.8% | -24.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.